跳至主要内容
临床试验/JPRN-UMIN000005338
JPRN-UMIN000005338已完成2 期

The efficacy of lafutidine in patients with chemotherapy-induced peripheral neuropathy treated with a taxane. - The efficacy of lafutidine in patients with chemotherapy-induced peripheral neuropathy treated with a taxane.

Yokohama City University0 个研究点目标入组 30 人开始时间: 2011年3月29日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1)with severe complications (such as liver failure, renal failure, heart failure) 2)with history of allergy 3)administration of Lafutidine within 2weeks before prior to treatment 4)receiving drugs to influence peripheral neuropathy 5)with peripheral neuropathy for other cause (such as severe edema, diabetes, vitamin B12 deficiency) 6)doctor's decision not to be registered to this study

研究者

相似试验